Lactobacillus rhamnosus gg on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 6, 2013, Pages 750-758

  Liu, Fangning ^a   Li, Guohua ^a   Wen, Ke ^a   Wu, Shaoping ^b   Zhang, Yongguo ^b   Bui, Tammy ^a   Yang, Xingdong ^a   Kocher, Jacob ^a   Sun, Jun ^b   Jortner, Bernard ^a   Yuan, Lijuan ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

Gastroenteritis; Gnotobiotic pigs; Intestinal epithelial barrier; Probiotic; Rotavirus

Indexed keywords

BETA CATENIN; CLAUDIN 3; CLAUDIN 4; MUCIN; OCCLUDIN; PROBIOTIC AGENT; TIGHT JUNCTION PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DIARRHEA; GASTROENTERITIS; GNOTOBIOTICS; HISTOPATHOLOGY; ILEUM; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; INTESTINE VILLUS ATROPHY; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAVIRUS INFECTION; SWINE; WESTERN BLOTTING;

ANIMALS; DIARRHEA; DISEASE MODELS, ANIMAL; FEMALE; GERM-FREE LIFE; ILEUM; INTESTINAL MUCOSA; INTESTINE, LARGE; LACTOBACILLUS RHAMNOSUS; MALE; MUCINS; PREVALENCE; PROBIOTICS; PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; SWINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84889650238     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182a356e1     Document Type: Article

References (47)

1. Guandalini S. Probiotics for children with diarrhea: an update. J Clin Gastroenterol 2008;42 (suppl 2):S53-7.
2. Guandalini S. Probiotics for children: use in diarrhea. J Clin Gastroenterol 2006;40:244-8. (Pubitemid 44309561)
3. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011;34:1079-87.
4. Liu F, Li G, Wen K, et al. Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics. Viral Immunol 2010; 23:135-49.
5. Landau D. Epithelial paracellular proteins in health and disease. Curr Opin Nephrol Hypertens 2006;15:425-9. (Pubitemid 44297985)
6. Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006;22:85-9. (Pubitemid 44090070)
7. Markov AG, Kruglova NM, Fomina YA, et al. Altered expression of tight junction proteins in mammary epithelium after discontinued suckling in mice. Pflugers Arch 2012;463:391-8.
8. West AB, Isaac CA, Carboni JM, et al. Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms. Gastroenterology 1988;94:343-52. (Pubitemid 18054769)
9. Beau I, Cotte-Laffitte J, Amsellem R, et al. A protein kinase A-dependent mechanism by which rotavirus affects the distribution and mRNA level of the functional tight junction-associated protein, occludin, in human differentiated intestinal Caco-2 cells. J Virol 2007; 81:8579-86. (Pubitemid 47242831)
10. Nava P, Lopez S, Arias CF, et al. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci 2004;117 (pt 23):5509-19. (Pubitemid 40012198)
11. Yuan L, Stevenson G, Saif L. Rotavirus and reovirus. In: Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ, eds. Diseases of Swine. Ames, IA: Blackwell Publishing; 2006:435-54.
12. Johnson-Henry KC, Donato KA, Shen-Tu G, et al. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 2008;76:1340-8. (Pubitemid 351561979)
13. Patel RM, Myers LS, Kurundkar AR, et al. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 2012;180:626-35.
14. Mack DR, Ahrne S, Hyde L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827-33. (Pubitemid 36613489)
15. Mack DR, Michail S,Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999;276 (4 pt 1):G941-50.
16. Mattar AF, Teitelbaum DH, Drongowski RA, et al. Probiotics upregulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002;18:586-90. (Pubitemid 36069911)
17. Caballero-Franco C, Keller K, De Simone C, et al. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292: G315-22. (Pubitemid 46090273)
18. Chen CC, Baylor M, Bass DM. Murine intestinal mucins inhibit rotavirus infection. Gastroenterology 1993;105:84-92. (Pubitemid 23234023)
19. Yolken RH, Ojeh C, Khatri IA, et al. Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J Infect Dis 1994;169:1002-6.
20. Ward LA, Rosen BI, Yuan L, et al. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996;77 (pt 7):1431-41. (Pubitemid 26248656)
21. Zhang W, Azevedo MS, Gonzalez AM, et al. Influence of probiotic Lactobacilli colonization on neonatal B cell responses in a gnotobiotic pig model of human rotavirus infection and disease. Vet Immunol Immunopathol 2008;122:175-81. (Pubitemid 351273815)
22. Meyer RC, Bohl EH, Kohler EM. Procurement and maintenance of germ-free swine for microbiological investigations. Appl Microbiol 1964;12:295-300.
23. Zhang W, Azevedo MS, Wen K, et al. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 2008;26:3655-61.
24. Yuan L, Ward LA, Rosen BI, et al. Systematic and intestinal antibodysecreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol 1996;70:3075-83 (Pubitemid 26121924)
25. Azevedo MS, Yuan L, Jeong KI, et al. Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus. J Virol 2005;79:5428-36. (Pubitemid 40548211)
26. Liao D, Luo Y, Markowitz D, et al. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One 2009;4:e7965.
27. Azevedo MS, Yuan L, Pouly S, et al. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J Virol 2006;80:372-82.
28. Portal-Celhay C, Bradley ER, Blaser MJ. Control of intestinal bacterial proliferation in regulation of lifespan in Caenorhabditis elegans. BMC Microbiol 2012;12:49.
29. Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997;25:516-9. (Pubitemid 27463287)
30. Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7.
31. Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis 2009;13:518-23.
32. Rosenfeldt V, Michaelsen KF, Jakobsen M, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 2002;21:411-6. (Pubitemid 34532935)
33. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000;30:54-60 (Pubitemid 30349946)
34. Azevedo MS, Zhang W, Wen K, et al. Lactobacillus acidophilus and Lactobacillus reuteri modulate cytokine responses in gnotobiotic pigs infected with human rotavirus. Benef Microbes 2012;3:33-42.
35. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008;28:740-50. (Pubitemid 351784512)
36. Howe KL, Reardon C, Wang A, et al. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am J Pathol 2005;167:1587-97. (Pubitemid 41713312)
37. Al-Sadi R, Boivin M. Ma T Mechanism of cytokine modulation of epithelial tight junction barrier. Front Biosci 2009;14:2765-78.
38. Kaeffer B. Mammalian intestinal epithelial cells in primary culture: a mini-review. In Vitro Cell Dev Biol Anim 2002;38:123-34. (Pubitemid 34507482)
39. Shirkey TW, Siggers RH, Goldade BG, et al. Effects of commensal bacteria on intestinal morphology and expression of proinflammatory cytokines in the gnotobiotic pig. Exp Biol Med (Maywood) 2006; 231:1333-45. (Pubitemid 44330569)
40. Banasaz M, Norin E, Holma R, et al. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol 2002;68:3031-4. (Pubitemid 34602028)
41. West NP, Pyne DB, Peake JM, et al. Probiotics, immunity and exercise: a review. Exerc Immunol Rev 2009;15:107-26.
42. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006;169:1901-9. (Pubitemid 351181952)
43. Ben-Lulu S, Pollak Y, Mogilner J, et al. Dietary transforming growth factor-beta 2 (TGF-beta2) supplementation reduces methotrexateinduced intestinal mucosal injury in a rat. PLoS One 2012;7:e45221.
44. McCracken VJ, Chun T, Baldeon ME, et al. TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp Biol Med (Maywood) 2002;227:665-70.
45. Van NielCW, Feudtner C, Garrison MM, et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109:678-84. (Pubitemid 34286304)
46. Majamaa H, Isolauri E, Saxelin M, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20:333-8.
47. Licciardi PV, Tang ML. Vaccine adjuvant properties of probiotic bacteria. Discov Med 2011;12:525-33.